In 2019, the US Food and Drug Administration (FDA) approved 48 novel drugs. Thirty of the 48 (62.5%) novel drug approvals were reviewed and approved through an expedited review pathway while 20 of the 48 (41.7%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2019.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.amjmed.2020.01.030 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!